Introduction: For the past decades long-term survival of oral squamous cell carcinoma (OSCC) patients remain unchanged which provides a wide platform for research. Caldesmon (CaD), an actin-myosin binding protein, has a contributing role in cytoskeleton modulation and cell motility. The aim of this study is to evaluate the expression of CaD in metastatic and non-metastatic OSCC and to discuss the possible role of CaD in epithelial mesenchymal transition. Materials and Methods: Archival blocks of 25 metastatic and 25 non-metastatic OSCC patients are included where CaD expression is evaluated immunohistochemically. Results: Overall expression and staining intensity of CaD were statistically significant in different grades of metastatic and non-metastatic OSCC. In summary, high expression of CaD is observed in increasing grades of OSCC but the metastatic potential of the tumour doesn't seem to have any relation with CaD.
Introduction
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide. Cancer is a complex system comprising of tumour cells, surrounding stroma, various types of mesenchymal cells, and extra-cellular matrix (ECM), which are collectively known as tumor microenvironment (TME). [1] The stroma comprises numerous non-cancerous cells such as fibroblasts, endothelial cells, pericytes, immune regulatory cells, and cytokines. [2] These activated fibroblasts reprogram and resemble like the normal myofibroblast which is the basic component in healing granulation tissue and chronic inflammation. The recruited myofibroblasts tend to aggregate peritumorally and encircle the carcinoma cells invading adjacent normal tissues. [3, 4] Cell adhesion and migration, responsible for various normal and pathological events such as malignancy, are controlled by a complex change in the cytoskeleton. In various studies Ca 2+ dependant regulation of smooth muscle and non-smooth muscle cells showed caldesmon (CaD) in the cytoskeleton as a regulatory protein functioning as actomyosin contractile system. [5, 6] CaD, encoded from CALD1 gene, has two different isoforms: a high molecular weight protein (h-CaD) restricted to actomyosin contractile structures in visceral and vascular smooth muscle. In migrating cells, low molecular weight (l-CaD) in non-smooth muscle cells localized in stress fibres and membrane ruffles. [7, 8] Myofibroblast usually is negative for smooth muscle antigen such as myosin chains, CaD, and desmin but studies are done where myofibroblast showed positive expression of smooth muscle antigen in areas surrounding more advanced stage of tumour cell differentiation. [9, 10] Increased expression of mesenchymal markers, and loss of cell-cell adhesion and epithelial cell markers, is a key event in tumour cell progression and invasion which contributes epithelial-mesenchymal transition (EMT). [11] This event in EMT is chiefly because of alteration in extracellular proteins and cell adhesion molecules in tumour cell. [12] Selective studies have discussed the overexpression of CaD in OSCC suggesting its vital role in cellular migration and invasion. In the present study, we evaluated and compared the CaD expression in metastatic and non-metastatic OSCC immunohistochemically in an attempt to explain its possible role in tumour cell progression and migration.
Materials and Methods
A total of 50 OSCC samples were collected from the archival blocks of the Department of Oral Maxillofacial Pathology and Oral Microbiology, Vinayaka Missions Sankarachariyar Dental College, Salem. Out of 50 study blocks 25 are metastatic and 25 from non-metastatic oral squamous cell carcinoma (OSCC) cases. Conventional OSCC occurring in any area of the oral cavity with or without regional lymph node metastasis was included whereas variants of OSCC were not included in the study. The ethical committee of Vinayaka Mission's Sankarachariyar Dental College, Salem (VMDC/ IEC/Approval No 80) approved this study on 13/10/2017.
Study Design
The archival blocks collected were subjected to immunohistochemical staining. The sections are treated with ready-to-use rabbit monoclonal anti-human CaD antibody (PathnSitu, CA-94551 USA), counterstained with Mayer's hematoxylin, dehydrated, cleared, and mounted. CaD expression was scored using Klein et al. [13] scoring system for both staining intensity and the percentage of cells stained. Accordingly scores 0, 1, 2, and 3 of staining intensity denoted negative, weak, mild, and strong, respectively. The percentage of cells taken from the stain were scored as 0-negative, grade 1--<30% positive cells, grade 2-30-60 % positive cells, and grade 3->60% positive cells. The final score for each case was calculated by adding the scores of proportion of positivity score and intensity score. The final score 0-1 was considered negative, score 1-2 was considered mild expression, score 2-4 was moderate expression, and score 4-6 was severe expression.
Statistical Analysis
The final data was analyzed using SPSS software version 11.5 (SPSS Inc., Chicago, IL). The significant difference between the groups are analyzed using Chi square test. P value less than 0.05 was considered as statistically significant.
Results
In immunohistochemical analysis of metastatic and nonmetastatic OSCC, CaD expression was observed in cell membrane and cytoplasm of tumour cells with more intensity in the periphery of tumour islands and adjacent stroma. In adjacent dysplastic surface epithelium of the tumour showed positivity in the basal cells. In few areas of tumor island, CaD expression was noted in newly formed blood vessels [ Figure 1 ].
In non-metastatic OSCC, the overall staining is graded as follows; grade 1 expression of CaD was observed in 90% of well-differentiated cases, 60% of grade 2 expression and 40% of grade 1 expression were noted in moderately differentiated OSCC. In poorly differentiated OSCC grade 3 expression was observed in 60% cases and grade 2 in 40% cases. The overall staining expression of CaD in non-metastatic OSCC shows a significant difference among the grades of OSCC with a P value of 0.001 [ Table 1 ]. The staining intensity was scored as weak, mild, and strong with the significant P value of 0.002 in different grades of non-metastatic OSCC [ Table 2 , Figure 2 ].
In metastatic OSCC overall staining was observed in different grades are as follows; 90% grade 1 expression was observed in well-differentiated cases, 90% of grade 2 expression in moderately differentiated cases, and 100% of grade 3 expression observed in poorly differentiated cases of OSCC with a significant P value of 0.001 [ Table 2 ]. Strong positivity and staining intensity of tumour cells were observed in poorly differentiated OSCC with high significant at P value of (0.001) [Tables 3 and 4, Figure 3 ]. When comparing the CaD expression in metastatic and non-metastatic OSCC, the overall staining and intensity of staining were not statistically significant.
Discussion
Stabilization of actin filaments, remodelling of cytoskeleton and cellular motility are regulated by the actin-binding protein, CaD. Role of CaD in the cytoskeletal rearrangement of non-smooth muscle is unclear. [14] In nonsmooth muscle cells, CaD is involved in the formation and maintenance of stress fibres, which is responsible for formation of adhesion sites in the tumour cell periphery. [15] 
Figure 1: Caldesmon expression in newly formed blood vessels in well differentiated squamous cell carcinoma
Tamara et al. [16] in 2005 investigated that CaD plays a vital role in the microfilament remodeling and cell motility of endothelial cells which is the early step in angiogenesis and thereby promotes invasiveness. The aggressiveness of a tumour chiefly depends upon the ability of cancer cells to invade adjacent tissue and undergo metastasis. Epithelial-mesenchymal transition is a complex process which is categorized into three types; including type 1 in embryogenesis, type 2 in wound healing, organ fibrosis, tissue regeneration, and type 3 where the cancer cells are involved in invasion and metastasis. [17] Previous studies highlighted the role of several growth factors and cytokines like TGF-β, EGF, insulin-like growth factor, hepatocyte growth factor, fibroblast growth factor, interleukin, and transcription factors that modulates the plasticity of tumour cells and promotes invasiveness. [18] [19] [20] [21] [22] Chang et al. [7] in 2013 noted increased CaD expression in metastatic OSCC with a poor prognosis. In our study CaD expression increased with increasing grade of OSCC which is similar to the previous studies. Based on our results, CaD expression is high in poorly differentiated metastatic and nonmetastatic OSCC significantly. Also, positive expression was noted in new blood vessels and surrounding stroma which denotes its increased potential for tumour progression and metastasis. When comparing the CaD expression in metastatic and non-metastatic OSCC, significant results were not obtained.
EMT is the first step for tumour progression and migration which leads to metastasis and influences the prognosis of the tumour. Few other markers like e-cadherin, IL-8, TGF-β, etc., have potential roles in epithelial-mesenchymal transition and migration of tumour cells. In summary, though there was significant overexpression of CaD from differentiated tumors to poorly differentiated tumors, metastatic potential of the 
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